AKBMo — Aker Biomarine ASA Cashflow Statement
0.000.00%
Last trade - 00:00- NOK4.71bn
- NOK6.09bn
- $199.00m
- 30
- 48
- 44
- 31
Annual cashflow statement for Aker Biomarine ASA, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -5.46 | -8.01 | 10 | -9 | 180 |
| Depreciation | |||||
| Non-Cash Items | 21.7 | 23.4 | 8.4 | 8.7 | -172 |
| Unusual Items | |||||
| Equity in Net Earnings/Losses | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -116 | -65.7 | -54.7 | -4.6 | -43.5 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Net Change in Other Assets & Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -51 | 0.729 | 15.1 | 47.4 | 12.2 |
| Capital Expenditures | -23.7 | -81.1 | -46.1 | -49.3 | -23.1 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | 21.7 | 1.9 | -10.3 | 0.4 | 403 |
| Sale of Business | |||||
| Sale of Fixed Assets | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -2.05 | -79.2 | -56.4 | -48.9 | 379 |
| Financing Cash Flow Items | -0.001 | 0.001 | — | — | — |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 50.2 | 78.9 | 52.5 | 6.7 | -404 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -2.93 | 0.454 | 11.2 | 5.2 | -12.4 |